ConductScience.org, home

Paper36498435

The First 30 Years of the Universal Hepatitis-B Vaccination-Program in Italy: A Health Strategy with a Relevant and Favorable Economic-Profile.

Boccalini S and 5 others. Int J Environ Res Public Health, 2022. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. The First 30 Years of the Universal Hepatitis-B Vaccination-Program in Italy: A Health Strategy with a Relevant and Favorable Economic-Profile. Papers, record 36498435. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36498435

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The First 30 Years of the Universal Hepatitis-B Vaccination-Program in Italy: A Health Strategy with a Relevant and Favorable Economic-Profile.
PubMed
Journal
Int J Environ Res Public Health
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
1.04
iCite
Revised in PubMed
2023-03-08
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boccalini SSarahttps://orcid.org/0000-0002-9695-7549
2Bonito BBenedetta
3Zanella BBeatricehttps://orcid.org/0000-0001-6718-1932
4Liedl DDavidehttps://orcid.org/0000-0002-1000-1475
5Bonanni PPaolohttps://orcid.org/0000-0003-2875-3744
6Bechini AAngelahttps://orcid.org/0000-0002-6013-8779

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis BMajor topic
Liver NeoplasmsMajor topic
Child
Humans
State Medicine
Immunization Programs
Cost-Benefit Analysis
Hepatitis B virus
Italy
Hepatitis B Vaccines

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18995940Long course and prognostic factors of virus-induced cirrhosis of the liver.Am J Gastroenterol1997https://conductscience.org/library/papers/8995940PubMed
210194831Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness.Vaccine1999https://conductscience.org/library/papers/10194831PubMed
333270480Need to take special care of non-responders to hepatitis B vaccination among health-care workers, students and chronic patients.Hum Vaccin Immunother2021https://conductscience.org/library/papers/33270480PubMed
429325525Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries.BMC Infect Dis2018https://conductscience.org/library/papers/29325525PubMed
524954675Hepatitis B virus infection.Lancet2014https://conductscience.org/library/papers/24954675PubMed
616249217A mathematical model to estimate global hepatitis B disease burden and vaccination impact.Int J Epidemiol2005https://conductscience.org/library/papers/16249217PubMed
711732013Chronic hepatitis B.Hepatology2001https://conductscience.org/library/papers/11732013PubMed
830889167Forty years (1978-2018) of vaccination policies in Italy.Acta Biomed2019https://conductscience.org/library/papers/30889167PubMed
923354158Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination.Hum Vaccin Immunother2013https://conductscience.org/library/papers/23354158PubMed
102131945Five years of vaccination campaign against hepatitis B in Italy in infants of hepatitis B surface antigen carrier mothers.Ital J Gastroenterol1990https://conductscience.org/library/papers/2131945PubMed
112526420A nationwide vaccination programme in Italy against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers.Vaccine1989https://conductscience.org/library/papers/2526420PubMed
1232235670Hepatitis B Seroprevalence in the Pediatric and Adolescent Population of Florence (Italy): An Update 27 Years after the Implementation of Universal Vaccination.Vaccines (Basel)2020https://conductscience.org/library/papers/32235670PubMed
1319877181Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety.Hepatology2010https://conductscience.org/library/papers/19877181PubMed
1412531340Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy.Vaccine2003https://conductscience.org/library/papers/12531340PubMed
1518269332Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.Clin Infect Dis2008https://conductscience.org/library/papers/18269332PubMed
1621756850The changing scenario of hepatocellular carcinoma over the last two decades in Italy.J Hepatol2012https://conductscience.org/library/papers/21756850PubMed
1715332269Role of beauty treatment in the spread of parenterally transmitted hepatitis viruses in Italy.J Med Virol2004https://conductscience.org/library/papers/15332269PubMed
181426884Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver.Gastroenterology1992https://conductscience.org/library/papers/1426884PubMed
1922387286What is the probability of being too old for salvage transplantation after hepatocellular carcinoma resection?Dig Liver Dis2012https://conductscience.org/library/papers/22387286PubMed
202366843Chronic hepatitis B.N Engl J Med1990https://conductscience.org/library/papers/2366843PubMed

See all 25 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42751130MZB1 expression levels are associated with long-term maintenance of high anti-HBs titers: single-cell RNA-seq with validation by nested case-control and intervention studies.Front Immunol2026https://conductscience.org/library/papers/42751130PubMed
42514028Downregulated HIPK2 Expression in T Cells Is Associated with Occult Hepatitis B Virus Infection.Microorganisms2026https://conductscience.org/library/papers/42514028PubMed
41491184Retrospective cohort study of hepatitis B immunization strategy effects in Beijing across 30 years.Nat Commun2026https://conductscience.org/library/papers/41491184PubMed
40432091Value of Vaccinations: A Fundamental Public Health Priority to Be Fully Evaluated.Vaccines (Basel)2025https://conductscience.org/library/papers/40432091PubMed
40006721Increasing Prevalence of Occult HBV Infection in Adults Vaccinated Against Hepatitis B at Birth.Vaccines (Basel)2025https://conductscience.org/library/papers/40006721PubMed
39591157Hepatitis B Virus-Related Cirrhosis and Hepatocellular Carcinoma Hospital Discharge Rates from 2005 to 2021 in Spain: Impact of Universal Vaccination.Vaccines (Basel)2024https://conductscience.org/library/papers/39591157PubMed
38952534Hepatitis-B immune status and vaccination in Family Medicine Practice: A retrospective study.Pak J Med Sci2024https://conductscience.org/library/papers/38952534PubMed
38793738Impact of the Universal Implementation of Adolescent Hepatitis B Vaccination in Spain.Vaccines (Basel)2024https://conductscience.org/library/papers/38793738PubMed
37692960Hepatitis B eradication: vaccine as a key player.Am J Transl Res2023https://conductscience.org/library/papers/37692960PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HBE13046PubTator's text mininghttps://conductscience.org/library/genes/3046

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36498435

GET https://conductscience.org/api/papers/v1/36498435/references?page=2